Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS researchers have been awarded funding from the Chan Zuckerberg Initiative to ensure that tendon samples from understudied ethnic groups are included in the Tendon Human Cell Atlas.

Montage of human faces © Gerd Altmann from Pixabay

Tendons are essential for all forms of movement but are prone to inflammation and tears, causing pain and loss of mobility for patients. As part of an international partnership, NDORMS researchers have been mapping the cells present in healthy human tendons across anatomical sites in the body for over the past year. By creating a dataset for healthy tendon cell types to input into the Human Cell Atlas, they are developing a molecular map that will provide a resource to understand tendon disease and to advance treatments.

The team has recently been awarded additional funding by the Chan Zuckerberg Initiative that ensures samples of tendon from ethnically underrepresented donors can be collected and mapped. The curation of an ethnically diverse database is fundamental to ensuring that future benefits are equitably distributed.

Sarah Snelling, Associate Professor at NDORMS and lead investigator of The Tendon Seed Network says: "This funding will allow us to build ethnic diversity into the Tendon Cell Atlas. By working with Prof Xavier Griffin (London) and Prof Chris Buckley (Birmingham/Oxford), we will expand the atlas to capture the cells present in the tendons of donors from underrepresented ethnic groups and ensure we deliver a robust cell atlas of tendon that better represents global populations."

A challenge for researchers has been the social and cultural barriers to participation found in different minority groups. "We will work with our patient involvement and engagement teams to better understand barriers to participation in research for minority ethnic groups and work with these communities to support their future participation," explained Dr Mathew Baldwin who is the clinical co-lead on the project.

Their goal is to collect healthy tendon tissue samples from Asian and Black patients, ensuring that over one third of the anatomical tendon sites profiled by the Tendon Seed Network will be from donors from ethnically understudied populations.

Norbert Tavares, Chan Zuckerberg Initiative Program Manager for Single-Cell Biology, said: "It is critical to include diverse tissue samples in the Human Cell Atlas so we can learn and grow from historical shortcomings and bias in genomics. While this effort is only the start of addressing diversity in the Human Cell Atlas in the long term, these projects will serve as an initial pilot to surface future opportunities to more deeply address these challenges for the future."

FUNDED BY

Chan Zuckerberg Initiative logo

Similar stories

New Associate Professors announced at NDORMS

The Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS.

COVID-19 vaccines shown to reduce infection by 90% in nursing homes

A new collaborative study between the Catalan Institute of Health, the Public Health Secreatariat of Catalonia, and the Centre for Statistics in Medicine, NDORMS, at the University of Oxford have confirmed that COVID-19 vaccines greatly reduce infections, hospitalisations and mortality for up to 6 months.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Unlocking the secrets of the microbiome

Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.

Into the future: watching biology unfold

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.

New Botnar Research Institute Director starts today

Professor Jonathan Rees begins his new role as Director of the Botnar Research Institute today, taking over from Professor Andrew Carr.